ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

Obituaries: Eleanor Nealson, 59, NCI Liaison to Patients, Formed consumer Advisory Group

October 29, 1999

More DCT Concepts Approved By Advisors

July 10, 1992

Clinton Budget For NIH “Disappointing,” AACR executive Director Says

May 7, 1993

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

House Subcommittee voted $1.011 Billion For NCU 1981 Fiscal Year Budget In Closed Door Meeting

August 8, 1980

New AIDs System For Classification Increase By 1% Cases Reported

August 1, 1986